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ABSTRACT 
Some anticancer molecules using natural flavonoid chrysin were designed and docking studies were performed using Molegro 
Virtual Docker (MVD) software. Of the available crystal structures of the non- mutated Homo sapiens, five were selected for the 
final docking studies. The docking results with selected crystal structures shown that designed legends forms hydrogen bonds with at 
least two out of three key active site residues (Asp, Val and Lys). It also form hydrogen bonds to other active site residues, in 
particular Glu. The average MolDock score and the MolDock Re-rank score were obtained as -156.704 Kcal/mol and-125.649 
Kcal/mol respectively. The docking results shown that some molecules fit well in the active site and interact with the residues in the 
active site which are crucial for their biological activity. 
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INTRODUCTION: 
Cancer is a group of diseases characterized by 
uncontrolled growth and multiplication of abnormal 
cells that invade and metastases to other parts of the 
body
1
. Several techniques have been adopted for the 
treatment and eradication of cancerous cells. These 
techniques involved surgery, radiation, immunotherapy, 
chemotherapy and chemoprevention. Ideal anticancer 
drugs would eradicate cancer cells without harming 
normal tissues. Chrysin, also known as 5, 7-
dihydroxyflavone with an IUPAC name of 5, 7-
dihydroxy 2-phenyl-4H-chromen-4-one, belongs to the 
flavone sub-class of flavonoids. Its chemical structure is 
essentially based on a three ring nucleus with a phenyl 
ring attached to position 2 of the fused bicyclic and 
rings. Flavonoids including flavones, flavonols, and 
flavones possess various biological activities as 
antioxidant, anticancer etc. chrysin as a flavonoids 
shown activity for anticancer activity
2
. 
Binding of a small molecule (ligand) with a large 
molecule (protein) is called docking. Docking is the 
process by which two molecules fit together in 3D 
space. Docking is a method which predicts the preferred 
orientation of one molecule to a second when bound to 
each other to form a stable complex
3
. 
 
MATERIALS AND METHODS: 
Designing of compounds 
New molecules were designed by combining chrysin 
and cycloalkane derivatives. Four Molecules were 
designed on the basis of literature of their biological 
response towards cancer cells (Figure 1) 
 
Target Selection 
Three targets (Table 1) were selected for performing 
docking studies to check the binding affinity of designed 
molecules with the target and to predict the potential 
molecules to be synthesized with the aim to have 
anticancer activity
4
. 
Software 
Ligand Preparation 
The structures of Chrysin with cyclic compounds were 
converted into suitable chemical information using 
Chemdraw ultra v 10.0 (Cambridge software), copied to 
Chem3D ultra v 10.0 to create a 3D model and, finally 
subjected to energy minimization using molecular 
mechanics (MM2). The minimization was executed until 
the root mean square gradient value reached a value 
smaller than 0.001kcal/mol
5
. 
 
 
Dangi et al                                                                                                         Journal of Drug Delivery & Therapeutics. 2017; 7(7):131-133                       
ISSN: 2250-1177                                                                             [132]                                                                             CODEN (USA): JDDTAO 
OHO
OH O
O
Cl
O
Cl
O
Cl
O
O
OO
O O
OO
O O
OO
O O
O
O O
O
Cl
O
O
O
O
O
O
O
 
Figure 1: Designed compounds 
Protein Selection 
The selection of protein for docking studies is based 
upon several factors i.e. structure should be determined 
by X-ray diffraction, and resolution should be between 
2.0-2.5Ao, it should contain a co-crystallized ligand; the 
selected protein should not have any protein breaks in 
their 3D structure. 
 
Table 1: Selected anticancer drug targets with PDB ID 
S. No. Name of anticancer target protein PDB ID 3D structure of target 
1 
Crystal structure of CphA N220G mutant with 
inhibitor 18 
 
3IOG 
 
2 
Crystal structure of a human cyclin-dependent 
kinase 6 complex with a flavonol inhibitor, 
fisetin 
 
1XO2 
 
3 
Structure determinants of phosphoinositide 3-
kinase inhibition 
 
1E8W 
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Protein Preparation 
All the X-ray crystal structures of the selected target 
proteins were obtained from the RCSB Protein Data 
Bank (http://www.rcsb.org/pdb). Subsequent to 
screening for the above specific standards the resultant 
protein targets. 
Software Method Validation 
Software method validation was performed in MVD 
Molegro Virtual Docker 6.0 2013 and Marvin Sketch 
Product version 6.2.3 2013 were using Protein Data 
Bank (PDB) protein 3IOG, 1XO2, 1E8W. 
RESULTS AND DISCUSSION 
Dockings results reveals that compound no. 4 has shown 
best affinity towards all the targets selected for the 
study. 
 
Figure 2: Biding affinity of Compound (a) with target 
(where carbon is grey, oxygen is red, nitrogen is blue 
and sulphur is yellow and hydrogen in white). Green 
lines represent the hydrogen bonds in between the 
ligand and the active site). 
PDB code Ligand name MolDock Score Rerank Score HBond 
3IOG Compound (a) -135.548(b) -106.292 -5.66085 
  
Figure 3: Biding affinity of Compound (b) with target (where carbon is grey, oxygen is red, nitrogen is blue and sulphur is 
yellow and hydrogen in white). Green lines represent the hydrogen bonds in between the ligand and the active site). 
PDB code Ligand name MolDock Score Rerank Score HBond 
1XO2 Compound (B) -155.357 -124.456 -3.68857 
 
 
Figure 4: Biding affinity of Compound (b) with target (where carbon is grey, oxygen is red, nitrogen is blue and sulphur is 
yellow and hydrogen in white). Green lines represent the hydrogen bonds in between the ligand and the active site). 
PDB code Ligand name MolDock Score Rerank Score HBond 
1E8W Compound (b) -126.682 -105.89 -4.50612 
 
REFERENCES: 
1. Ahmedin J, Siegel R, Ward E, Hao Y, Xu J, Murray T, Thun 
MJ, Cancer Statistics, CA, 2008, 58, 71–96. 
2. Mohammed HA, Ba LA, Bhurkhloz T, Schumann E, Diesel 
B, Zapp J, Kiemer AK, Riesc, Hartmann RW, Hosny M, 
Jacob C, Facile synthesis of chrysin-derivatives with 
promising activities as aromatase inhibitors, NPC, 2011, 6, 
31-34. 
3. Gehlhaar DK, Verkhivker G, Rejto PA, Fogel DB, Fogel LJ, 
Freer ST, Docking Conformationally Flexible Small 
Molecules into a Protein Binding Site through Evolutionary 
Programming, Proceedings of the Fourth International 
Conference on Evolutionary Programming, 1995, 123-124. 
4. Ramachandran GN, Sasisekharan V,) Conformation of 
polypeptides and proteins, Adv Protein Chem, 1968, 23, 243-
438.  
5. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, 
Weissig H, Shindyalov IN, Bourne PE, The Protein Data 
Bank, Nucleic Acids Res, 2000, 24, 235-242. 
 
